CY1117370T1 - Φαρμακευτικη παστιλια με βραδεια απελευθερωσης του δραστικου παραγοντα - Google Patents
Φαρμακευτικη παστιλια με βραδεια απελευθερωσης του δραστικου παραγονταInfo
- Publication number
- CY1117370T1 CY1117370T1 CY20161100300T CY161100300T CY1117370T1 CY 1117370 T1 CY1117370 T1 CY 1117370T1 CY 20161100300 T CY20161100300 T CY 20161100300T CY 161100300 T CY161100300 T CY 161100300T CY 1117370 T1 CY1117370 T1 CY 1117370T1
- Authority
- CY
- Cyprus
- Prior art keywords
- release
- days
- active factor
- pharmaceutical paste
- pharmaceutical
- Prior art date
Links
- 239000008253 pharmaceutical paste Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 210000000214 mouth Anatomy 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000007937 lozenge Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- General Preparation And Processing Of Foods (AREA)
- Road Signs Or Road Markings (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Confectionery (AREA)
Abstract
Φαρμακευτική παστίλια προς εκμύζηση ψημένης ζάχαρης, στερεάς υφής, προοριζόμενη να διαλύεται εντός της στοματικής κοιλότητας, περιλαμβάνουσα τουλάχιστον ένα δραστικό παράγοντα, χαρακτηριζόμενη από το ότι περιλαμβάνει εξ άλλου τουλάχιστον έναν παράγοντα πλέγματος επιτρέποντα την επιβράδυνση της απελευθερώσεως του ενός ή περισσότερων δραστικών παραγόντων οι οποίοι παραμένουν έτσι σε παρατεταμένη επαφή με τη στοματοφαρυγγική κοιλότητα, ενώ ο χρόνος διαλύσεως εντός της στοματικής κοιλότητας είναι τουλάχιστον 15 λεπτά.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0105554A FR2823974B1 (fr) | 2001-04-25 | 2001-04-25 | Pastille medicamenteuse a liberation lente du principe actif |
EP10154760.2A EP2184057B1 (fr) | 2001-04-25 | 2002-04-25 | Pastille médicamenteuse a libération lente du principe actif |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117370T1 true CY1117370T1 (el) | 2017-04-26 |
Family
ID=8862665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161100300T CY1117370T1 (el) | 2001-04-25 | 2016-04-12 | Φαρμακευτικη παστιλια με βραδεια απελευθερωσης του δραστικου παραγοντα |
Country Status (12)
Country | Link |
---|---|
US (1) | US8545870B2 (el) |
EP (3) | EP2184057B1 (el) |
AT (1) | ATE465721T1 (el) |
BR (1) | BRPI0209221B8 (el) |
CA (1) | CA2445200C (el) |
CY (1) | CY1117370T1 (el) |
DE (1) | DE60236149D1 (el) |
DK (2) | DK2184057T3 (el) |
ES (2) | ES2565464T3 (el) |
FR (1) | FR2823974B1 (el) |
PT (1) | PT1383484E (el) |
WO (1) | WO2002085334A1 (el) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040052851A1 (en) * | 2002-09-16 | 2004-03-18 | Graff Allan H. | Modified release oral dosage form |
SE0302947D0 (sv) | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
UA112974C2 (uk) * | 2010-09-16 | 2016-11-25 | Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид | Нікотиновмісна композиція (варіанти) |
FR2978916B1 (fr) * | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US20130206150A1 (en) * | 2012-02-10 | 2013-08-15 | R.J. Reynolds Tobacco Company | Multi-layer smokeless tobacco composition |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
US9044035B2 (en) | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
FR2993778B1 (fr) | 2012-07-30 | 2016-06-17 | Pf Medicament | Pastilles a cinetiques multiples de liberation de principes actifs |
US10244786B2 (en) | 2013-10-03 | 2019-04-02 | Altria Client Services Llc | Tobacco lozenge |
US10105320B2 (en) | 2013-10-03 | 2018-10-23 | Altria Client Services | Soluble fiber lozenge |
US9999243B2 (en) | 2013-10-03 | 2018-06-19 | Altria Client Services Llc | Exhausted tobacco lozenge |
US11779045B2 (en) | 2013-10-03 | 2023-10-10 | Altria Client Services Llc | Dissolvable-chewable exhausted-tobacco tablet |
US9351936B2 (en) * | 2013-10-03 | 2016-05-31 | Altria Client Services Llc | Nicotine lozenge |
US9375033B2 (en) | 2014-02-14 | 2016-06-28 | R.J. Reynolds Tobacco Company | Tobacco-containing gel composition |
CN108684938A (zh) * | 2018-04-16 | 2018-10-23 | 广州智特奇生物科技股份有限公司 | 一种植物精油包被液、微胶囊植物精油及其制备方法 |
US11672862B2 (en) | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
CA3160750A1 (en) | 2019-12-09 | 2021-06-17 | Anthony Richard Gerardi | Oral product comprising a cannabinoid |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
US11883527B2 (en) | 2019-12-09 | 2024-01-30 | Nicoventures Trading Limited | Oral composition and method of manufacture |
US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
US11889856B2 (en) | 2019-12-09 | 2024-02-06 | Nicoventures Trading Limited | Oral foam composition |
US11839602B2 (en) | 2020-11-25 | 2023-12-12 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1144915A (en) * | 1966-11-24 | 1969-03-12 | Armour Pharma | Improvements in or relating to pastille formulations |
US5785989A (en) * | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
GB8518927D0 (en) * | 1985-07-26 | 1985-09-04 | Vincent Processes Ltd | Tablets |
US4983398A (en) * | 1987-12-21 | 1991-01-08 | Forest Laboratories, Inc. | Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates |
US5200194A (en) * | 1991-12-18 | 1993-04-06 | Alza Corporation | Oral osmotic device |
DE19536394A1 (de) * | 1995-09-29 | 1997-04-03 | Basf Ag | Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze |
DE19606968C2 (de) * | 1996-02-24 | 1998-07-09 | Suedzucker Ag | Verwendung von 1,1-GPS in Hartkaramellen |
ATE247951T1 (de) * | 1996-05-13 | 2003-09-15 | Novartis Consumer Health Sa | Mundfreisetzungssystem |
TW474824B (en) * | 1996-09-13 | 2002-02-01 | Basf Ag | The production of solid pharmaceutical forms |
IT1297233B1 (it) * | 1996-10-29 | 1999-08-09 | Montefarmaco Spa | Composizioni farmaceutiche solide in forma di caramelle contenenti disinfettanti e sostanze mucoadesive per una disinfezione topica |
US5942244A (en) * | 1997-07-31 | 1999-08-24 | Farmo-Nat Ltd. | Local oral herbal slow release tablets |
US20040101543A1 (en) * | 2002-03-22 | 2004-05-27 | John Liu | Nicotine-containing oral dosage form |
-
2001
- 2001-04-25 FR FR0105554A patent/FR2823974B1/fr not_active Expired - Lifetime
-
2002
- 2002-04-25 EP EP10154760.2A patent/EP2184057B1/fr not_active Expired - Lifetime
- 2002-04-25 DK DK10154760.2T patent/DK2184057T3/en active
- 2002-04-25 DE DE60236149T patent/DE60236149D1/de not_active Expired - Lifetime
- 2002-04-25 CA CA2445200A patent/CA2445200C/fr not_active Expired - Lifetime
- 2002-04-25 AT AT02726276T patent/ATE465721T1/de active
- 2002-04-25 EP EP10182581A patent/EP2269588A1/fr not_active Withdrawn
- 2002-04-25 EP EP02726276A patent/EP1383484B1/fr not_active Expired - Lifetime
- 2002-04-25 WO PCT/FR2002/001421 patent/WO2002085334A1/fr not_active Application Discontinuation
- 2002-04-25 US US10/475,778 patent/US8545870B2/en active Active
- 2002-04-25 BR BRPI0209221A patent/BRPI0209221B8/pt not_active IP Right Cessation
- 2002-04-25 DK DK02726276.5T patent/DK1383484T3/da active
- 2002-04-25 ES ES10154760.2T patent/ES2565464T3/es not_active Expired - Lifetime
- 2002-04-25 PT PT02726276T patent/PT1383484E/pt unknown
- 2002-04-25 ES ES02726276T patent/ES2340761T3/es not_active Expired - Lifetime
-
2016
- 2016-04-12 CY CY20161100300T patent/CY1117370T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0209221B1 (pt) | 2018-03-13 |
US20060171994A1 (en) | 2006-08-03 |
WO2002085334A1 (fr) | 2002-10-31 |
CA2445200C (fr) | 2011-09-06 |
FR2823974A1 (fr) | 2002-10-31 |
EP1383484A1 (fr) | 2004-01-28 |
PT1383484E (pt) | 2010-05-27 |
DK2184057T3 (en) | 2016-04-18 |
DK1383484T3 (da) | 2010-06-07 |
DE60236149D1 (de) | 2010-06-10 |
ATE465721T1 (de) | 2010-05-15 |
CA2445200A1 (fr) | 2002-10-31 |
ES2565464T3 (es) | 2016-04-04 |
ES2340761T3 (es) | 2010-06-09 |
BR0209221A (pt) | 2004-06-15 |
EP2184057B1 (fr) | 2016-01-13 |
US8545870B2 (en) | 2013-10-01 |
BRPI0209221B8 (pt) | 2021-07-27 |
EP2184057A1 (fr) | 2010-05-12 |
EP2269588A1 (fr) | 2011-01-05 |
EP1383484B1 (fr) | 2010-04-28 |
FR2823974B1 (fr) | 2004-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1117370T1 (el) | Φαρμακευτικη παστιλια με βραδεια απελευθερωσης του δραστικου παραγοντα | |
ATE374016T1 (de) | Tablette mit hohem wirkstoffgehalt | |
ATE444738T1 (de) | Verbesserte essbare filmformulierungen mit maltodextrin | |
DK1175149T3 (da) | Desinficerende sammensætning baseret på H2O2, syrer og metaliioner | |
AR024384A1 (es) | UNA FORMA DE DOSIFICACIoN FARMACÉUTICA DE DISOLUCIoN INSTANTÁNEA Y UN MÉTODO PARA PREPARARLA | |
AR018143A1 (es) | Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca | |
PT1212317E (pt) | Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes | |
ITMI20001732A0 (it) | Composizioni farmaceutiche per il trattamento di mucositi e stomatiti | |
NO20024528L (no) | Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen | |
NO20031622L (no) | Medisinske blandinger som raskt desintegrerer i munnhulen og fremgangsmåtefor fremstilling av samme | |
EE04278B1 (et) | Pantoprasoolmagneesiumdihüdraat, seda sisaldav ravim ja selle kasutamine | |
CL2004000551A1 (es) | Compuestos derivados de triazol sustituidos con biarilo, sus sales, bloqueadores del canal de sodio; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento o prevencion del dolor. | |
JP2005516946A5 (el) | ||
NO331215B1 (no) | Kit av deler og farmasoytiske formuleringer | |
NO994431L (no) | Ny formulering | |
JO3106B1 (ar) | مستحضر صلب يشمل بيوجليتازون وجليمبيريد وإستر حمض دهني لعديد أوكسي إيثيلين سوربيتان | |
ATE439828T1 (de) | In der mundhíhle dispergierbare feste pharmazeutische form | |
AR020291A1 (es) | Aparato para introducir diversos ingredientes en forma solida en una masa de jabon | |
DE60331648D1 (de) | Puffende orale darreichungsformen | |
PL366855A1 (en) | Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof | |
DE50004623D1 (de) | Modensynchronisierter Festkörperlaser | |
IT1311590B1 (it) | Metodo per la realizzazione di una calzatura e calzatura da essoottenibile. | |
CY1113164T1 (el) | Στοματικως αποσαθρουμενη κονις περιλαμβανουσα κιλοσταζολη και μαννιτολη | |
DE60033117D1 (de) | Verhinderung des Festklebens von Hartkonfekten | |
FI963394A0 (fi) | Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia |